实用医学杂志 ›› 2021, Vol. 37 ›› Issue (6): 705-708.doi: 10.3969/j.issn.1006⁃5725.2021.06.002

• 专家笔谈 • 上一篇    下一篇

脓毒症相关急性肾损伤发病机制和新型生物标志物研究进展

康凌垲, 李小悦, 张倩   

  1. 1 桂林医学院附属医院急诊科(广西桂林 541001);2 遵义医科大学第五附属(珠海)医院重症医学科(广东 珠海 519116);3 陆军军医大学第二附属医院肿瘤科(重庆 400037)

  • 出版日期:2021-03-25 发布日期:2021-03-25
  • 通讯作者: 李小悦 E⁃mail:euyeuy1983@126.com
  • 基金资助:

    国家自然科学基金(编号:81960361);广西自然科 学基金(编号:2017GXNSFBA198044);广西科技基地和人才专项 (编号:桂科AD19110084);广西医疗卫生适宜技术开发与推广应用 项目(编号:S2018074);遵义医科大学博士科研启动资金(编号: BS2020⁃02);珠海市新型冠状病毒疫情防控应急研究项目(编号: ZH22036302200061PWC);贵州省卫生健康委科学技术基金项目 (编号:gzwjkj2020⁃1⁃020);贵州省科技支撑计划防控新型冠状病毒 技术攻关及集成应用专项项目(编号:黔科合支撑[2020]4Y196号)

Advances in pathogenesis and novel biomarkers of sepsis associated acute kidney injury

KANG Lingkai* LI Xiaoyue,ZHANG Qian.   

  1. Department of Emergency,Affiliated Hospital of Guilin Medical College,Guangxi 541001,China

  • Online:2021-03-25 Published:2021-03-25
  • Contact: LI Xiaoyue E⁃mail:euyeuy1983@126.com

摘要:

脓毒症是急危重症患者主要死亡原因之一。脓毒症相关急性肾损伤(SA⁃AKI)与脓毒症患者不良预后相关,其发病机制复杂,目前认为主要与免疫炎症反应、凝血级联激活、肾细胞凋亡和线粒体动力学异常有关。对SA⁃AKI患者进行早期诊断和治疗有助于降低病死率,既往基于血清肌酐的诊断标准存在局限性。最新研究发现多种新型生物标志物参与SA⁃AKI发生发展,可能是SA⁃AKI早期诊断和治疗新的靶点。本文主要针对SA⁃AKI病理生理机制及其相关新型生物标志物进行探讨并做简要综述。

关键词:

脓毒症相关急性肾损伤, 机制, 生物标志物

Abstract:

Sepsis is one of the main causes of death in patients with acute and critical illness. Acute kidney injury(SA ⁃AKI)is associated with poor prognosis in sepsis patients,which is complex pathogenesis and currently believed to be mainly related to immune inflammatory response,coagulation cascade activation,renal cell apoptosis,and mitochondrial kinetics abnormities. Early diagnosis and treatment of SA ⁃AKI patients can reduce the mortality. Previous diagnostic criteria based on serum creatinine have limitations. Recent studies have found that a variety of novel biomarkers are involved in the occurrence and development of SA⁃AKI,which may be new targets for the early diagnosis and treatment of SA ⁃AKI. In this brief reviewed paper,the pathophysiological mechanism of SA⁃AKI and its related novel biomarkers are discussed.

Key words:

sepsis associated acute kidney injury, mechanism, biomarker